Gwenn Hansen
Vermögen: 3 Mio $ am 30.09.2026
Vermögen: 3 Mio $ am 30.09.2026
Gwenn M.
Hansen is Chief Scientific Officer at Nurix Therapeutics, Inc. since 2020, with employment at the company starting in 2015.
Formerly, served as Associate Professor at Baylor College of Medicine.
Education includes undergraduate studies at Gustavus Adolphus College and a doctorate from the University of Tennessee.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.10.2026 | 117’227 ( 0.11% ) | 3 Mio $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| NURIX THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2019 |
| Unternehmen | Position | Ende |
|---|---|---|
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Nurix Therapeutics, Inc.
Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
Gustavus Adolphus College
Gustavus Adolphus College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Tennessee
University of Tennessee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen